Detalles de la búsqueda
1.
Immunogenicity and safety of SpikoGen®, an adjuvanted recombinant SARS-CoV-2 spike protein vaccine as a homologous and heterologous booster vaccination: A randomized placebo-controlled trial.
Immunology
; 167(3): 340-353, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35758850
2.
Evaluation of the Physicochemical and Biological Stability of Cetuximab under Various Stress Condition.
J Pharm Pharm Sci
; 22(1): 171-190, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31112673
3.
Comparative immunogenicity and safety of SpikoGen®, a recombinant SARS-CoV-2 spike protein vaccine in children and young adults: An immuno-bridging clinical trial.
Int Immunopharmacol
; 127: 111436, 2024 Jan 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38147778
4.
Safety and immunogenicity of SpikoGen®, an Advax-CpG55.2-adjuvanted SARS-CoV-2 spike protein vaccine: a phase 2 randomized placebo-controlled trial in both seropositive and seronegative populations.
Clin Microbiol Infect
; 28(9): 1263-1271, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35436611
Resultados
1 -
4
de 4
1
Próxima >
>>